LPL Financial
CUE icon

LPL Financial’s Cue Biopharma CUE Stock Holding History

LPL Financial’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.58K Sell
520
-1,026
-66% -$9.57K ﹤0.01% 5953
2025
Q4 		$14.2K Hold
1,546
– – ﹤0.01% 5834
2025
Q3 		$33.3K Sell
1,546
-434
-22% -$10.2K ﹤0.01% 5685
2025
Q2 		$40.5K Buy
1,980
+549
+38% +$11.7K ﹤0.01% 5386
2025
Q1 		$39.1K Hold
1,431
– – ﹤0.01% 5176
2024
Q4 		$46.8K Buy
1,431
+833
+139% +$31.3K ﹤0.01% 5109
2024
Q3 		$13.6K Hold
598
– – ﹤0.01% 5110
2024
Q2 		$22.2K Buy
598
+167
+39% +$8.26K ﹤0.01% 4927
2024
Q1 		$24.4K Hold
431
– – ﹤0.01% 4828
2023
Q4 		$34.1K Buy
431
+79
+22% +$5.65K ﹤0.01% 4695
2023
Q3 		$24.3K Hold
352
– – ﹤0.01% 4596
2023
Q2 		$38.6K Hold
352
– – ﹤0.01% 4456
2023
Q1 		$37.7K Hold
352
– – ﹤0.01% 4348
2022
Q4 		$30.1K Hold
352
– – ﹤0.01% 4328
2022
Q3 		$24K Buy
+352
New +$30.3K ﹤0.01% 4305

Other funds holding CUE

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
GWMR
GC Wealth Management RIA Cambridge, Massachusetts $1.73B AUM 16.14% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
AWM
Angeles Wealth Management Santa Monica, California $1.84B AUM 19.34% 1-Year Est. Return

LPL Financial's CUE Position: Q1 2026 in Review

LPL Financial reduced its Cue Biopharma (CUE) stake by 66% in Q1 2026, selling an estimated $9.57K and leaving 520 shares worth $3.58K. The position accounts for ﹤0.01% of the portfolio, ranked #5953.

LPL Financial first reported a position in CUE in Q3 2022 and has held it in 15 quarters since. The position peaked at $46.8K in Q4 2024. 55 funds tracked by Wall St. Rank hold CUE as of Q1 2026.

  • LPL Financial held 520 shares of Cue Biopharma worth $3.58K as of Q1 2026.
  • LPL Financial sold 1,026 Cue Biopharma shares in Q1 2026, an estimated $9.57K.
  • Cue Biopharma made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5953 holding.
  • LPL Financial first reported a position in Cue Biopharma in Q3 2022 and has held it in 15 quarters since.
  • LPL Financial's Cue Biopharma position peaked at $46.8K in Q4 2024.
  • 55 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.